Search filters

List of works by Tobias Heintges

Abrogation of hepatitis C virus NS3 helicase enzymatic activity by recombinant human antibodies

scientific article

Autoimmune thrombocytopenia induced by PEG-IFN-alpha2b plus ribavirin in hepatitis C.

scientific article published in March 2002

Cloning and molecular characterization of human high affinity antibody fragments against Hepatitis C virus NS3 helicase

scientific article

Combination treatment of IFNalpha2b and ribavirin in patients with chronic hepatitis C and persistently normal ALTs

scientific article

Exploring the effect of primary tumor sidedness on therapeutic efficacy across treatment lines in patients with metastatic colorectal cancer: analysis of FIRE-3 (AIOKRK0306).

scientific article

Extended treatment duration for hepatitis C virus type 1: comparing 48 versus 72 weeks of peginterferon-alfa-2a plus ribavirin

scientific article published in April 2006

FOLFIRI plus cetuximab or bevacizumab for advanced colorectal cancer: final survival and per-protocol analysis of FIRE-3, a randomised clinical trial

scientific article published on 06 November 2020

FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial

scientific article

FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab for metastatic colorectal cancer (FIRE-3): a post-hoc analysis of tumour dynamics in the final RAS wild-type subgroup of this randomised open-label phase 3 trial

scientific article

HED

scholarly article

Hepatitis C virus core protein induces cell proliferation and activates ERK, JNK, and p38 MAP kinases together with the MAP kinase phosphatase MKP-1 in a HepG2 Tet-Off cell line

scientific article published on January 2002

Impact of Subsequent Therapies on Outcome of the FIRE-3/AIO KRK0306 Trial: First-Line Therapy With FOLFIRI Plus Cetuximab or Bevacizumab in Patients With KRAS Wild-Type Tumors in Metastatic Colorectal Cancer

scientific article published on 10 August 2015

Peginterferon-alpha-2a (40KD) and ribavirin for 16 or 24 weeks in patients with genotype 2 or 3 chronic hepatitis C.

scientific article published on August 2005

Psychomotor slowing in hepatitis C and HIV infection

scientific article published in February 2004

Relapse to prior therapy is the most important factor for the retreatment response in patients with chronic hepatitis C virus infection

scientific article published in September 2007

Relation of early tumor shrinkage (ETS) observed in first-line treatment to efficacy parameters of subsequent treatment in FIRE-3 (AIOKRK0306).

scientific article published on 29 December 2016

Relevance of liver-limited disease in metastatic colorectal cancer: Subgroup findings of the FIRE-3/AIO KRK0306 trial

scientific article

SEN virus does not affect treatment response in hepatitis C virus coinfected patients but SEN virus response depends on SEN virus DNA concentration

scientific article

SEN virus has an adverse effect on the survival of HIV-positive patients

scientific article published in July 2005

SEN virus infection

scientific article published on May 2004

SEN virus seroprevalence in HIV positive patients: association with immunosuppression and HIV-replication

scientific article published on 10 December 2004

Single-nucleotide variants, tumour mutational burden and microsatellite instability in patients with metastatic colorectal cancer: Next-generation sequencing results of the FIRE-3 trial

scientific article published on 14 August 2020

Specific targeting of hepatitis C virus core protein by an intracellular single-chain antibody of human origin

scientific article

Treatment of chronic hepatitis delta with pegylated interferon-alpha2b

scientific article

Update hepatitis D

scientific article published in March 2006

Paulina is supported by:

About Paulina

Help